BSEBharat Parenterals LtdMinimalNeutral
Announced Mon, 25 May · 14:28 IST

Annual Secretarial Compliance report for the Year ended March 31, 2026, Pursuant to regulations 24A of SEBI (LODR) Regulations, 2015.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.4%1-day move
₹1396.80
prior close
₹1325.75
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+1.7+1.7+1.7-6.4-6.6-3.7-5.1-4.9-1.2-6.9-4.1+10.3
Up moveDown movePending
AI summary

Bharat Parenterals Ltd has submitted its Annual Secretarial Compliance Report for FY 2025-26 (ending March 31, 2026), certified by Practicing Company Secretaries Jigar Trivedi & Co. The auditor confirmed the company complied with all applicable SEBI regulations including LODR, PIT regulations, and Depositories regulations during the review period. One past deviation was noted: a 4-day delay in filing the Annual Report for FY 2023-24, which resulted in a fine of Rs. 4,720 (including taxes) paid to BSE. The company stated it has since taken due care to avoid such delays. No new non-compliances were observed, no SEBI or exchange actions were taken against the company, and all secretarial standards, board processes, and compliance mechanisms were found satisfactory.

Likely market impact

This is a routine compliance filing showing the company is in good standing with SEBI regulations for FY 2025-26. The past filing delay has been resolved with a fine, and no fresh violations were detected, which is positive for investors concerned about governance standards.